您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2015, Vol. 53 ›› Issue (4): 75-79.doi: 10.6040/j.issn.1671-7554.0.2014.711

• 临床医学 • 上一篇    下一篇

白细胞介素33在脑血管病患者血清中的表达及其作用机制

于磊, 李振   

  1. 中国人民解放军第456医院神经内科, 山东 济南 250031
  • 收稿日期:2014-10-15 修回日期:2014-12-01 出版日期:2015-04-10 发布日期:2015-04-10
  • 通讯作者: 李振.E-mail:lizh1970@163.com E-mail:lizh1970@163.com

Expression of interleukin-33 and its function in the serum of patients with cerebrovascular disease

YU Lei, LI Zhen   

  1. Department of Neurology, No.456 Hospital of PLA, Jinan 250031, Shandong, China
  • Received:2014-10-15 Revised:2014-12-01 Online:2015-04-10 Published:2015-04-10

摘要: 目的 探讨脑血管疾病患者血清中白细胞介素33(IL-33)水平与颈动脉粥样硬化斑块稳定性及脑梗死的关系及其作用机制.方法 采用ELISA方法检测脑梗死组(n=63)、短暂性脑缺血发作组(n=30)及正常对照组(n=15)血清中IL-33的表达水平;采用Western blotting、荧光定量PCR(qRT-PCR)和ELISA法检测体外培养的人外周血单个核细胞(PBMC)和U937细胞在接受外源性IL-33刺激后,MMP-9和Cox-2的表达量变化.结果 脑梗死组IL-33的表达水平低于对照组和短暂性脑缺血发作组(P均 <0.01);脑梗死组中不稳定斑块、稳定斑块和无斑块患者血清中IL-33的表达水平逐渐降低(P <0.01);脑梗死组中,与无糖尿病和高血脂症的患者相比,合并糖尿病和高脂血症的患者血清中IL-33水平降低(P均 <0.01);外源性IL-33刺激可下调外周血单核细胞和U937细胞中MMP-9和Cox-2的表达和分泌量.结论 IL-33可被作为预测脑梗死及不稳定性粥样硬化斑块的潜在的血清标志物和治疗靶点.

关键词: 外科手术, 白细胞介素33, 动脉粥样硬化, 基质金属蛋白酶9, 血清, 亲情护理服务, 心理护理

Abstract: Objective To explore the prognostic value of serum interleukin-33(IL-33) level in cerebral infarction with carotid atherosclerotic plaque and the pathological functions of IL-33. Methods ELLSA was applied to detect serum IL-33 levels in the patients with cerebral infarction(n=63)and transient ischemic attack(n=30), as well as normal controls(n=15). Western blotting,qRT-PCR and ELISA were used to detect the expression levels of MMP9 and Cox-2 in PBMC and U937 cells after IL-33 stimulation. Results The serum level of IL-33 was lower in patients with cerebral infarction, compared with those in transient ischemic attack and normal controls(all P<0.01). IL-33 expression levels decreased in turn in cerebral infarction patients with unstable plaque, stable plaque and without plaque(P <0.01). IL-33 expression level was also lower in the serum of cerebral infarction patients concurrent with diabetes and hyperlipidaemia(all P <0.01). Furthermore, MMP9 and Cox-2 expression levels in PBMC and U937 could be down-regulated after treatment with IL-33. Conclusion IL-33 can be regarded as a potential serum marker or treatment target of cerebral infarction and unstable atherosclerotic plaques.

Key words: Atherosclerosis, Surgery, Matrix metalloproteinase 9, Interleukin-33, Serum, Psychological nursing, Kindred-like nursing

中图分类号: 

  • R743
[1] McLaren JE, Michael DR, Salter RC, et al. IL-33 reduces macrophage foam cell formation[J]. J Immunol, 2010, 185(6):1222-1229.
[2] Demyanets S, Kaun C, Pentz R, et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature[J]. J Mol Cell Cardiol, 2013, 60:16-26.
[3] Willems S, Hoefer I, Pasterkamp G. The role of the interleukin 1 receptor-like 1 (ST2) and interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment[J]. Minerva Med, 2010, 103(6):513-524.
[4] 中华医学会第四届全国脑血管病学术会议组. 各类脑血管病诊断要点[J].中华神经科杂志, 1996, 29(6):379-380.
[5] 杨华,王全懂. 老年颈动脉粥样斑块患者血清MMP-9 TIMP-1与hs-CRP水平变化[J]. 四川解剖学杂志, 2013, 21(4):16-18.
[6] 曲晓峰, 杨海山, 刘亚洁,等. 磁共振动态增强扫描(DCE-MRI)与动脉粥样硬化斑块内新生微血管相关性实验研究[J].基础研究与临床, 2010, 31(6):45-47. QU Xiaofeng, YANG Haishan, LIU Yajie, et al. Correlative experiment study of dynamic contrast enhanced MR imaging and neovascularization in atherosclerotic plaques of rabbits[J]. Basic & Clinical Medicine, 2010, 31(6):45-47.
[7] Businaro R, Tagliani A, Buttari B, et al. Cellular and molecular players in the atherosclerotic plaque progression[J]. Ann N Y Acad Sci, 2012, 1262:134-141.
[8] Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’?[J]. PLoS One, 2008, 3(10):e3331.doi: 10.1371/journal.pone.0003331.
[9] Willems S, Hoefer I, Pasterkamp G. The role of the interleukin 1 receptor-like 1 (ST2) and interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment[J]. Minerva Med, 2012, 103(6):513-524.
[10] 刘晶瑶,邢英琦. 急性脑梗死患者外周血白介素-33 水平的变化及其临床意义[J].临床神经病学杂志, 2013, 26(1):59-60. LIU Jingyao, XING Yingqi. Chang and its clinical significance of level of peripheral blood interleukin-33 in acute cerebral infarction patients[J]. Journal of Clinical Neurology, 2013, 26(1):59-60.
[11] 范天全,于海奕,郭艳红,等. 急性冠状动脉综合征患者血浆白细胞介素33浓度变化及其与预后的关系[J]. 临床荟萃, 2009, 24(11):924-927. FAN Tianquan, YU Haiyi, GUO Yanhong, et al. Relationships between level of plasma interleukin-33 and prognosis in patients with acute coronary syndrome[J]. Clinical Focus, 2009, 24(11):924-927.
[12] Gómez-Hernández A, Sánchez-Galán E, Martín-Ventura JL, et al. Atorvastatin reduces the expression of prostaglandin E2 receptors in humancarotid atherosclerotic plaques and monocytic cells: potential implications forplaque stabilization[J]. J Cardiovasc Pharmacol, 2006, 47(1):60-69.
[13] 姜红菊,李润智,王营,等. 冠状动脉粥样硬化斑块形态及介入治疗与MMP-9的关系[J].山东大学学报:医学版, 2008, 46(10):35-38. JIANG Hongju, LI Runzhi, WANG Ying, et al. Relationship between the plasma level of matrix metalloproteinase-9 and structural characteristics of plaques and percutaneous coronary intervention[J]. Journal of Shandong University: Health Sciences, 2008, 46(10):35-38.
[14] Kunisch E, Chakilam S, Gandesiri M, et al. IL-33 regulates TNF-α dependent effects in synovial fibroblasts[J].Int J Mol Med, 2012, 29(4):530-540.
[15] Sussmann M, Sarbia M, Meyer-Kirchrath J, et al. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins[J]. Circ Res, 2004, 94(5):592-600.
[16] Hemshekhar M, Thushara RM, Jnaneshwari S, et al. Attenuation of adjuvant-induced arthritis by dietary sesamol via modulation of inflammatory mediators, extracellular matrix degrading enzymes and antioxidant status[J]. Eur J Nutr, 2013, 52(7):1787-1799.
[1] 李波波 李道堂 刘曙光 王兴武. 食管癌患者血清中DKK-1的表达[J]. 山东大学学报(医学版), 2209, 47(6): 58-61.
[2] 张辉 时庆 侯怀水 李栋. 人脐带间充质干细胞的无动物血清培养及向肝细胞诱导分化[J]. 山东大学学报(医学版), 2209, 47(6): 88-.
[3] 李宁 张征 张宏群 高希宝. 济南居民膳食硒摄入量与血清硒参考值调查[J]. 山东大学学报(医学版), 2209, 47(6): 121-122.
[4] 张媛 李英敏 冯月秋 常彩云 潘华伟 王束玫. 血清脂联素水平与肥胖、胰岛素抵抗的关系探讨[J]. 山东大学学报(医学版), 2209, 47(6): 124-.
[5] 付洁琦,张曼,张晓璐,李卉,陈红. Toll样受体4抑制过氧化物酶体增殖物激活受体γ加重血脂蓄积的分子机制[J]. 山东大学学报 (医学版), 2020, 1(7): 24-31.
[6] 尹妮,杨关林,姜钧文,王春田,王凤耀,贾连群,高晓宇,潘嘉祥,李芹,李佳,冯元洁,高玉竹,周鹤,张哲. 巴马小型猪冠状动脉粥样硬化模型的评价方法[J]. 山东大学学报(医学版), 2017, 55(7): 1-5.
[7] 刘京康,杨建勇,孟丽华,姜洁. 血清miR-17-92簇在HPV阳性宫颈癌中的早期诊断价值[J]. 山东大学学报(医学版), 2017, 55(5): 86-90.
[8] 李岩,郭珺,王荣祺,刘永玲. 难治性癫痫相关Sturge-Weber综合征7例临床及病理分析[J]. 山东大学学报(医学版), 2017, 55(4): 91-95.
[9] 张云华,李杰. 颈动脉斑块内新生血管显影程度及血浆Lp-PLA2水平对急性脑梗死的临床诊断价值[J]. 山东大学学报(医学版), 2017, 55(3): 112-116.
[10] 王谋龙,陈永坤,邢德广,曲良锁,王成伟. 经颅多普勒超声早期预测动脉瘤夹闭术后迟发性脑缺血的临床分析[J]. 山东大学学报(医学版), 2017, 55(11): 38-41.
[11] 魏丹丹,张澄. 血管紧张素Ⅳ型受体过表达对早期动脉粥样硬化斑块形成的影响[J]. 山东大学学报(医学版), 2016, 54(8): 1-5.
[12] 林栋,管庆波. 2型糖尿病男性患者血清睾酮水平低下对非酒精性脂肪肝的影响[J]. 山东大学学报(医学版), 2016, 54(7): 33-37.
[13] 王丹,亓恒涛,孙书珍. 原发性肾病综合征儿童颈动脉结构和功能改变[J]. 山东大学学报(医学版), 2016, 54(5): 88-91.
[14] 马琳,张冬,唐蕾,叶嗣源,焉传祝,曹丽丽. 肌萎缩侧索硬化预后相关的血液学标志物[J]. 山东大学学报(医学版), 2016, 54(4): 46-50.
[15] 孙鹏飞,孟晓,张凯,黎莉. 抵抗素样分子 β在动脉粥样硬化斑块稳定性中的作用[J]. 山东大学学报(医学版), 2016, 54(3): 1-4.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!